ASTH · Astrana Health
AI read · Good for ASTH
The AI's read
More of Astrana Health’s growth is coming from its existing operations, not just acquisitions. Texas operations are becoming profitable faster than expected, and adjusted EBITDA grew faster than sales. Still, Medicaid and exchange plan membership fell, and the company kept its full-year adjusted EBITDA forecast unchanged. Expected 2027 growth and improving Texas results make the overall report positive despite those limits.